KURE ETF

KURE ETF
$17.65
See how much of KURE you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Oct 1, 2026

Net Assets
$114M
Expense Ratio
0.65%
Dividend Yield (Current)
3.81%
Holdings
50
Inception Date
Jan 31, 2018
Fund Family
KraneShares
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+7.95%
1 Year-3.67%
3 Year+3.58%
5 Year-8.88%

Asset Allocation

Stocks: 99.82%
Cash: 0.18%
See how much of KURE you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
6160:HKBeigene Ag8.83%
1801:HKInnovent Biologics Inc8.56%
2269:HKWuxi Biologics Cayman Inc8.06%
603259:SHWuxi Apptec Co. Ltd. Class A5.79%
9926:HKAkeso Inc4.68%
Top 10 Concentration: 55.86%Report Date: Oct 1, 2026
Download all 50 holdings for KURE
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.81%
Frequency
Annually
Latest Distribution
$0.71
Dec 22, 2025
12M Distributions
1 payment
Total: $0.71

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This ETF
PRO
Peer Avg
PRO

KURE ETF Overview

KURE ETF (KraneShares MSCI All China Health Care Index ETF) is managed by KraneShares with $114.0M in net assets. KURE expense ratio is 0.65%, holding 50 positions across sectors including Health Care. Inception date: 2018-01-31.

KURE performance shows a YTD return of 7.95%. The 1-year return is -3.67% and the 5-year return is -8.88%. KURE dividend yield stands at 3.81%, paid annually.

KURE top holdings include Beigene Ag (8.8%), Innovent Biologics Inc (8.6%), Wuxi Biologics Cayman Inc (8.1%), Wuxi Apptec Co. Ltd. Class A (5.8%), Akeso Inc (4.7%). Go to all KURE holdings, KURE sectors, or KURE dividends.

KURE can be compared against other funds. Use KURE overlap to find shared positions, or KURE vs another fund for a side-by-side view. KURE alternatives are available via the screener, along with tax-loss harvesting opportunities.

1 Month
+4.70%
YTD
+7.95%
1 Year
-3.67%
3 Year
+3.58%

Top 10 Holdings (55.9% of portfolio)

#TickerNameSectorWeight
16160:HKBeigene AgUnknown8.83%
21801:HKInnovent Biologics IncHealth Care8.56%
32269:HKWuxi Biologics Cayman IncUnknown8.06%
4603259:SHWuxi Apptec Co. Ltd. Class AUnknown5.79%
59926:HKAkeso IncUnknown4.68%
6600276:SHJiangsu Hengrui Medicine Co LtdUnknown4.45%
7300760:SHShenzhen Mindray Bio-Medical ElectronicUnknown4.36%
81093:HKCSPC Pharmaceutical Group Limited ShsHealth Care3.78%
91177:KYSino Biopharmaceutical LimitedUnknown3.74%
101548:HKGenscript Biotech CorpUnknown3.61%